key: cord-0291394-faayuv8l
authors: Alhudiri, I. M.; Ramadan, A. M.; Ibrahim, K. I.; Eljilani, M.; Aboud, A. A.; Salem, M. A.; Elgheriani, H. M.; Elzagheid, A.
title: Whole-genome sequencing of SARS-COV-2 reveals a substantially lower frequency of the UK variant than previously announced in Libya
date: 2021-07-06
journal: nan
DOI: 10.1101/2021.07.03.21257942
sha: c54a2791afd9d50c83a1eefc57738d297cdb4115
doc_id: 291394
cord_uid: faayuv8l

A cluster-5 variant was detected in September 2020 in minks and humans in Denmark and currently classified as Alpha or B.1.1.7 strain. This variant presents several mutations in the spike region (S) which could increase the transmissibility of the virus 43-90% over previously circulating variants. The national center for disease control (NCDC) announced on 24th February 2021 the discovery of B.1.1.7 strain in Libya using a reverse-transcriptase PCR assay for S-gene target failure (SGTF) and reported that 25% of the tested samples were UK variant. This assay relies on the specific identification of the H69-V70 deletion in S gene which causes S gene drop out in RT-PCR; characteristic of the UK variant (B.1.1.7). This letter discusses our whole genome sequencing results of positive SARS-COV-2 samples with SGTF collected between 25th February - 4th March 2021 in Libya.

A SARS-CoV-2 spike (S) deletion H69-V70 was detected in cluster- 5 We sent the extracted RNA samples for SARS-COV-2 WGS to a genomic analysis laboratory in Spain for WGS because of limited sequencing facilities in Libya. Next generation sequencing of libraries was done using Illumina platform followed by sequence mapping using Sophia MMD Software. Determination of strains, number of variants in . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 6, 2021. Our data suggest that B.1.5252 is spreading widely in Libya and absence of S gene should not be routinely interpreted as B.1.1.7. This reinforces the need for whole-genome sequencing to first identify the reason for SGTF before using RT-PCR testing as a tool for surveillance for variants of concern. We also emphasize on the critical role of international collaboration especially in developing countries, for building capacity and advancing research in this time of the pandemic.

Authors declare that they have no conflict of interests.

Ethical approval All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This study was approved by the Biotechnology Research Center Bioethics Committee.

Informed consent was obtained from all individual participants included in the study.

Bal A, Destras G, Gaymard A, et al. Two-step strategy for the identification of SARS-CoV-2 variant of concern 202012/01 and other variants with spike deletion H69-V70, . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted July 6, 2021. ; https://doi.org/10.1101/2021.07.03.21257942 doi: medRxiv preprint

Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England

Preliminary genomic characterisation of an emergent SARS-CoV-2 lineage in the UK defined by a novel set of spike mutations -SARS-CoV-2 coronavirus

NCDC statements about covid-19

Multiplex qPCR discriminates variants of concern to enhance global surveillance of SARS-CoV-2

Tracking SARS-CoV-2 variants